We just filed an amicus brief in the Supreme Court on behalf of 360 repro health researchers explaining why dispensing mifepristone by mail and at pharmacies is safe and backed by science!
BREAKING UPDATE: Today, the U.S. Supreme Court granted a stay of an order issued by the Fifth Circuit Court of Appeals in Louisiana v. FDA. The FDA’s current rules, which allow people to receive mifepristone by mail or pharmacy, are now in place as the case proceeds on the merits.
The Fifth Circuit's ruling in Louisiana v. FDA could eliminate mail and pharmacy access to mifepristone nationwide. @uclarepropolicy.bsky.social filed an amicus brief urging SCOTUS to reverse the decision. Here, @melissagoodman.bsky.social, CRHLP’s executive director, explains what's at stake.
Today, 360 researchers—led by ANSIRH & @uclarepropolicy.bsky.social—filed an amicus brief in LA v. FDA, urging SCOTUS to follow science & reject restrictions on mifepristone.
Eliminating telehealth by mail & pharmacy would ban safe care for people who need it most. www.ansirh.org/research/res...
Cathren Cohen (she/her)
ANSIRH
UCLA Law Center on Repro Health, Law, & Policy
A new policy brief from CRHLP and the Mother Infant Cash Coalition examines the baseline demographics of 977 participants across four unconditional direct cash assistance programs serving pregnant and postpartum people nationwide.
law.ucla.edu/sites/defaul...
Join CRHLP and Los Angeles Guild for Reproductive Health on June 11th, from 6-8pm for Community & Conversation: Reproductive Health in America!
Staff Attorney Cathren Cohen will be joining for a discussion about the state of reproductive health locally and nationally.
RSVP here: lnkd.in/gTHJYew9
